CIK 0001842952
- Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863738787
- Phone
- +1 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 5,823 shares at $0.84 ($4,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 5,606 shares at $0.87 ($4,901)
- 4 Open-market buy Chief Executive Officer bought 5,040 shares at $0.97 ($4,900)
- 4 Open-market buy Chief Executive Officer bought 7,027 shares at $0.70 ($4,901)
- 4 Open-market buy Chief Executive Officer bought 6,839 shares at $0.72 ($4,901)
- 4 Open-market buy Chief Executive Officer bought 6,783 shares at $0.74 ($4,995)
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.74 ($18,500)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $0.74 ($14,796)
- 4 Open-market buy Chief Legal Officer, Corp. Sec bought 6,000 shares at $0.85 ($5,095)
- 4 Open-market buy Chief Executive Officer bought 13,000 shares at $1.85 ($24,064)
- 4 Open-market buy Chief Financial Officer bought 15,000 shares at $1.80 ($27,000)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.95 ($19,500)
- 4 Derivatives Options or other derivatives
Page 3 of 5 · 88 filings